Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

https://www.news-medical.net/news/20251217/Flow-chemistry-AI-and-NMR-A-next-gen-approach-to-scalable-API-production.aspx In this interview, News Medical speaks with Guillaume Bentzinger, Project Manager at Novalix; Luis Carrillo, Managing Director at De Dietrich France; Philippe Robin CEO of Alysophil; and Alejandro Bara-Estaún, Solution Product Manager at Bruker about how flow chemistry, artificial intelligence (AI), and nuclear magnetic resonance (NMR) are being integrated to transform the production of active pharmaceutical ingredients (APIs).